United States Securities and Exchange Commission · EDGAR Accession 0001750795-26-000002

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 1750795
Period 2025-12-31

Aphios Pharma LLC

Limited PartnershipDEIncorporated 2018NORTH READING, MAaphios.com
B

Financial Condition

two fiscal years, as filed
Pre-revenue7 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income00
Total assets00
Cash & equivalents00
Accounts receivable00
Short-term debt37,46952,291▼ 28%
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.